Journal Article (Review Article) DKFZ-2026-02442

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Reirradiation of recurrent brain tumors: a review by the ESTRO CNS Focus Group

 ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Elsevier Amsterdam

Clinical and translational radiation oncology 62, 101260 () [10.1016/j.ctro.2026.101260]
 GO

Abstract: Purpose: Reirradiation has become an area of increasing clinical and scientific interest, particularly in neuro-oncology. This non-systematic review on central nervous system (CNS) tumors by the CNS focus group of the European Society for Radiotherapy and Oncology provides a pragmatic synthesis of the available evidence, excluding gliomas. We address key questions related to patient selection, fractionation, technical considerations, and treatment safety. Methods: Relevant studies on the use of reirradiation for meningiomas, ependymomas, brain metastases, and pituitary neuroendocrine tumors, as well as on the management of radiation necrosis, have been reviewed and summarized. Results: Reirradiation has been used with varying success in primary and secondary brain tumors. The appropriate use of reirradiation requires consideration of numerous factors, including, but not limited to, prior treatment courses, fractionation, dose to organs at risk, imaging findings, the volume of the recurrent tumor, and the interval since prior treatments. The vast majority of available studies are limited by their retrospective design, lack of standardization in reporting, and overall heterogeneity across cohorts and treatments. Conclusion: Several reirradiation studies across different tumor entities suggest potential efficacy and safety in carefully selected patients. However, important limitations remain, underscoring the need for well-designed prospective studies with rigorous reporting in both primary and secondary brain tumors.

Classification:

Note: #DKTKZFB9#

Contributing Institute(s):
  1. DKTK Koordinierungsstelle Tübingen (TU01)
  2. DKTK Koordinierungsstelle Berlin (BE01)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-10-05, last modified 2026-10-06



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)